Glycomet 850 mg (Metformin) – Product Overview

Glycomet 850 mg is a prescription oral antidiabetic tablet produced by USV Pvt Ltd. Each strip contains ten tablets, and the product is offered in pack sizes of one hundred, two hundred, or three hundred tablets to suit long‑term treatment needs. The active ingredient is metformin hydrochloride at a strength of eight hundred fifty milligrams per tablet. The film‑coated formulation is intended for once‑or twice‑daily use in adults with type 2 diabetes who require additional glycemic control beyond diet and exercise. Regulatory agencies in several countries have approved the medication, and it appears on the World Health Organization’s Essential Medicines List for diabetes therapy, highlighting its clinical importance and wide availability.

What is Glycomet 850 mg (Metformin)

Metformin, the generic name for the active component of Glycomet 850 mg, belongs to the biguanide class and works chiefly by lowering hepatic glucose output. It inhibits gluconeogenesis in the liver and improves insulin sensitivity in muscle and adipose tissue, allowing cells to take up glucose more efficiently. Unlike some other oral hypoglycemics, metformin does not stimulate insulin secretion, which gives it a low risk of causing hypoglycemia when used alone. The 850 mg dose is a standard therapeutic strength that can reduce fasting plasma glucose and improve overall blood‑sugar control when combined with lifestyle changes. Metformin is not metabolized extensively; it is excreted unchanged in the urine.

Uses and Benefits

Glycomet 850 mg is approved for the management of type 2 diabetes when diet, exercise, or a single oral agent are insufficient. It is often used as first‑line therapy because it lowers HbA1c by about one to two percent and is weight‑neutral or modestly weight‑reducing, which is beneficial for overweight patients. Clinical data show that consistent use reduces the risk of microvascular complications such as retinopathy and nephropathy. The drug is also investigated for off‑label uses like polycystic ovary syndrome and weight management, though these applications should be supervised by a healthcare professional. Real‑world studies suggest that patients who stay on metformin experience fewer hospitalizations for high‑blood‑sugar emergencies.

How It Works

The mechanism of metformin involves activation of AMP‑activated protein kinase (AMPK), a cellular energy sensor that suppresses glucose production in the liver. By inhibiting enzymes such as glucose‑6‑phosphatase, metformin reduces hepatic gluconeogenesis. At the same time, it enhances insulin signaling in peripheral tissues, promoting translocation of GLUT4 transporters to the cell membrane and increasing glucose uptake. Metformin also alters gut microbiota composition, which may contribute to improved insulin sensitivity. These combined actions lower both fasting and post‑prandial glucose levels without stimulating insulin release, making the drug a safe option for many patients.

Dosage Guidelines

Initial dosing of Glycomet 850 mg is usually one tablet taken once daily with the evening meal to reduce gastrointestinal upset. After one week, the dose may be increased to 850 mg twice daily, taken with breakfast and dinner, for a maximum daily dose of 1700 mg. Dose escalation should be guided by periodic measurement of fasting glucose, post‑prandial glucose, and HbA1c every four to six weeks. Patients with an estimated glomerular filtration rate (eGFR) below forty‑five milliliters per minute per 1.73 square meters should have their maximum daily dose limited to 1000 mg, and metformin must be stopped if eGFR falls below thirty milliliters per minute. The tablet should be swallowed whole with food.

Side Effects

The most common adverse reactions are gastrointestinal, including nausea, vomiting, diarrhea, abdominal discomfort, and a transient metallic taste. These symptoms are usually mild and improve with continued use or by taking the tablet with meals. Less frequently, long‑term metformin can lead to vitamin B12 deficiency, which may cause peripheral neuropathy or anemia; regular laboratory checks are recommended. Rarely, the drug can cause lactic acidosis, a serious metabolic emergency characterized by rapid breathing, severe fatigue, muscle pain, and dizziness. Immediate medical attention is required if these signs appear. Management of mild stomach upset often involves dose reduction, administration with food, or switching to an extended‑release formulation, which has a lower incidence of these effects.

Warnings and Precautions

Before starting metformin, clinicians must evaluate renal function, liver health, and cardiovascular status. The medication is contraindicated in patients with an eGFR below thirty milliliters per minute per 1.73 square meters or a history of lactic acidosis. Caution is advised in those with acute kidney injury, severe dehydration, or conditions that reduce tissue perfusion such as heart failure or sepsis. Concomitant use of radiographic contrast agents that are eliminated renally requires temporary discontinuation of metformin for at least forty‑eight hours after the procedure. Alcohol intake should be moderate, and patients should be instructed to report any new medications or supplements. Pregnant or breastfeeding women should discuss the risks and benefits with their physician.

Frequently Asked Questions

1. Can Glycomet 850 mg be taken during pregnancy? Metformin is generally considered safe in pregnancy and is sometimes used for gestational diabetes, but the decision should be made by a qualified healthcare professional based on individual risk assessment.
2. How long does it take to see a reduction in blood sugar levels? Glycemic improvements can be observed within 1–2 weeks, though the full therapeutic effect may require several weeks to months as the dose is titrated.
3. Is Glycomet 850 mg available over the counter? No, it is a prescription medication and must be obtained with a valid medical prescription.
4. What should I do if I miss a dose? Take the missed dose as soon as you remember, unless it is nearly time for the next scheduled dose; then skip the missed dose and resume the regular schedule.
5. Can I use Glycomet together with other antidiabetic drugs? Yes, metformin is often combined with sulfonylureas, DPP‑4 inhibitors, or insulin, but dosage adjustments may be necessary to avoid hypoglycemia.

For additional clinical guidance, refer to authoritative resources such as the U.S. Food and Drug Administration, the National Library of Medicine’s MedlinePlus, and the National Institutes of Health.

Related Products

• Glizid 80 mg (Gliclazide)
• Semanize 4 mg (Semaglutide)
• Semaglutide 4 mg (Generic)
• Glinate 60 mg (Nateglinide)
• Diabetrol Tablets 5 mg/500 mg (Glibenclamide Metformin)
• Glucobay 50 mg (Acarbose)
• Glypride 4 mg (Glimepiride)
• Mignar 25 mg (Miglitol)
• PPG 0.3 mg (Voglibose)
• Prandial 0.3 MD (Voglibose)
• Rybelsus 3 mg (Semaglutide)
• Glycomet GP 2 Tablet (Metformin/Glimepiride)